[1]Patent:US2002/77337,2002,A1,
[2]ACSMedicinalChemistryLetters,2015,vol.6,#3,p.359-362
1019021-85-2
123531-52-2
158980-21-3
38922-77-9
70705-33-8
367500-94-5
366017-09-6 | Mubritinib | AA0078QG | MFCD09954135
375345-95-2 | Ly451395 | AA0079FO | MFCD18251566
36415-21-1 | 2-(Furfurylthio)ethylamine | AA0079ZX | MFCD01075029
111439-76-0 | Silane,dimethoxy(1-methylethyl)(2-methylpropyl)- | AA007AHV | MFCD00239345
1070879-58-1 | 4-Bromo-2-methyl-8-trifluoromethylquinoline | AA007B3G | MFCD11505142
108857-24-5 | 2-Amino-5-iodo-3-methylbenzoic acid | AA007BM0 | MFCD09029816
17288-54-9 | 5-(Benzyloxy)-1H-pyrrolo[2,3-c]pyridine | AA007C8B | MFCD09038914
3364-80-5 | Thiazole-4-carboxaldehyde | AA007CQH | MFCD00626896
171879-75-7 | 2-[4-(Methylsulfanyl)phenyl]benzonitrile | AA007DBC | MFCD05981388
34581-23-2 | 1-(3-Methylbutyl)piperazine | AA007E02 | MFCD08442096